Hubei Humanwell Pharmaceutical Excipients Co., Ltd. is a high-tech enterprise specializing in the production of pharmaceutical empty capsules. It has established a quality managementsystem according to cGMP, has gained HALAL, KOSHER, ISO9001, IS022000 and other international certifications, has passed the EU registration, and is applying for US DMF.
It proposes the strategic positioning of Service Provider of Functional Capsules, and has developed a series of functional capsules such as HPMC 2.0, Shatterproof Capsule, Immediate Release Capsule, and Slowly Crosslinked Capsule. It has technical solutions that do not contain titanium dioxide and sodium dodecyl sulfate in line with the international regulations. Not sterilized by ethylene oxide, without adding preservatives, HumanwellCaps capsules can better meet customers' personalized and innovative preparation needs. At present, HumanwellCaps capsules have been exported to more than 20 countries and regions in Europe, America, Southeast Asia, Africa, etc., providing high-quality capsules and customized solutions for global customers.
In 2024, HumanwellCaps will move to the new smart campus with a total investment of 1 billion yuan. Based on the principle of High-Standard Planning, High-Starting-Point Construction, High-Quality Management and High-Efficiency Operation, a world-class research institute of pharmaceutical excipients, intelligent workshops, and the supporting offices have been established. As a partner in the development stage of HumanwellCaps, IBM will facilitate HumanwellCaps to accelerate the digital transformation, to build an international and intelligent green factory, and strive to become a benchmark enterprise in the global pharmaceutical excipients segmentation field.
Technology and innovation are the guarantee for the healthy development Of Humanwellcaps, as well as the source of the company's rapid development. The company has an independent "pharmaceutical auxiliary research center", a 4000M2 research and development complex, a membrane material laboratory and a refined synthesis laboratory, and specializes in the research and development of empty capsules, medicinal capsule materials and special excipients. Work with innovation. The research center currently has 50 professional R&D personnel, including 13 senior engineers and 37 engineers. It has good basic conditions for R&D and a sound scientific and technological innovation management system.
In order to better develop scientific and technological innovation, the research center attaches great importance to the training and construction of R&D teams, regularly sends R&D personnel to participate in various academic seminars, and actively conducts academic exchanges with experts and professors from major universities or scientific research institutions to improve R&D Professional level and comprehensive quality of personnel. At the same time, Humanwellcaps maintains close production-university-research cooperation with Huazhong University of Science and Technology, Wuhan University, Hubei Institute of Technology and other institutions of higher learning. "Expert Workstation" and other industry-university-research cooperation platforms introduce technology and talents, improve enterprise R&D capabilities and R&D management levels, and realize complementary technologies, talents, and resources.
Contact Us
Tel/WhatsApp: +86-18120439171
E-mail: info@humanwellcaps.com
Address:No.439 Hebei Avenue, Chibi, Hubei Province, 437300, China.
Copyright @2021 Hubei Humanwell pharmaceutical excipients Co., Ltd. All rights reserved. Hubei ICP No.19006649 SupportedIPV6
+86-18120439171
+86-18120439171
Message 
@2021 Hubei Humanwell pharmaceutical excipients Co., Ltd.
Hubei ICP No.19006649 SupportedIPV66